Targeting of Slc25a21 Is Associated with Orofacial Defects and Otitis Media Due to Disrupted Expression of a Neighbouring Gene
暂无分享,去创建一个
Thomas M. Keane | Jacqueline K. White | N. Karp | C. Lelliott | R. Ramirez-Solis | K. Steel | D. Adams | T. Keane | N. Ingham | C. Scudamore | E. Ryder | Anna-Karin B Gerdin | J. Bussell | J. Estabel | D. Carragher | Wai-In Chan | S. Pearson | Simon A. Maguire | Nicolas Walker | Selina A. Pearson | Selina Pearson | R. Ramírez‐Solís
[1] R. Ramirez-Solis,et al. Molecular Characterization of Mutant Mouse Strains Generated from the EUCOMM/KOMP-CSD ES Cell Resource , 2013, Mammalian Genome.
[2] Damian Smedley,et al. Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many Genes , 2013, Cell.
[3] M. Bhutta,et al. What Have We Learned from Murine Models of Otitis Media? , 2013, Current Allergy and Asthma Reports.
[4] F. Palmieri. The mitochondrial transporter family SLC25: identification, properties and physiopathology. , 2013, Molecular aspects of medicine.
[5] Jacqueline K. White,et al. The mouse genetics toolkit: revealing function and mechanism , 2011, Genome Biology.
[6] J. Harrow,et al. A conditional knockout resource for the genome-wide study of mouse gene function , 2011, Nature.
[7] K. Steel,et al. Using the Auditory Brainstem Response (ABR) to Determine Sensitivity of Hearing in Mutant Mice , 2011, Current protocols in mouse biology.
[8] M. Schachner,et al. Short DNA sequences inserted for gene targeting can accidentally interfere with off‐target gene expression , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] I. Cuthill,et al. Reporting : The ARRIVE Guidelines for Reporting Animal Research , 2010 .
[10] D. Kleinjan,et al. Cis-ruption mechanisms: disruption of cis-regulatory control as a cause of human genetic disease. , 2009, Briefings in functional genomics & proteomics.
[11] A. Bradley,et al. Agouti C57BL/6N embryonic stem cells for mouse genetic resources , 2009, Nature Methods.
[12] D. Ovchinnikov. Alcian blue/alizarin red staining of cartilage and bone in mouse. , 2009, Cold Spring Harbor Protocols.
[13] D. Adams,et al. Contemporary approaches for modifying the mouse genome , 2008, Physiological genomics.
[14] S. O'Kane,et al. Temporal and spatial expression of Pax9 and Sonic hedgehog during development of normal mouse palates and cleft palates in TGF-β3 null embryos , 2007 .
[15] Wolfgang Wurst,et al. A Mouse for All Reasons , 2007, Cell.
[16] R. Kist,et al. Reduction of Pax9 gene dosage in an allelic series of mouse mutants causes hypodontia and oligodontia. , 2005, Human molecular genetics.
[17] Ferdinando Palmieri,et al. The mitochondrial transporter family (SLC25): physiological and pathological implications , 2004, Pflügers Archiv.
[18] Kuniya Abe,et al. Identification of Cis-regulatory elements in the mouse Pax9/Nkx2-9 genomic region: implication for evolutionary conserved synteny. , 2003, Genetics.
[19] Jean-François Nicolas,et al. CpG content affects gene silencing in mice: evidence from novel transgenes , 2003, Genome Biology.
[20] P. Patel,et al. Novel missense mutations and a 288‐bp exonic insertion in PAX9 in families with autosomal dominant hypodontia , 2003, American journal of medical genetics. Part A.
[21] D. Milewicz,et al. A novel mutation in human PAX9 causes molar oligodontia. , 2002, Journal of dental research.
[22] L. Paulin,et al. Identification of a nonsense mutation in the PAX9 gene in molar oligodontia , 2001, European Journal of Human Genetics.
[23] Paul Scherz,et al. Functional analysis of secreted and transmembrane proteins critical to mouse development , 2001, Nature Genetics.
[24] J. Walker,et al. Identification of the Human Mitochondrial Oxodicarboxylate Carrier , 2001, The Journal of Biological Chemistry.
[25] K. Kratochwil,et al. Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. , 1998, Genes & development.
[26] T. Ley,et al. Long-range disruption of gene expression by a selectable marker cassette. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] T. Ley,et al. Analysis of mice containing a targeted deletion of beta-globin locus control region 5' hypersensitive site 3 , 1996, Molecular and cellular biology.
[28] B. Wold,et al. Know Your Neighbors: Three Phenotypes in Null Mutants of the Myogenic bHLH Gene MRF4 , 1996, Cell.
[29] R. Balling,et al. Characterization and developmental expression of Pax9, a paired-box-containing gene related to Pax1. , 1995, Developmental biology.
[30] M. Groudine,et al. An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the beta-globin locus control region. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Durán,et al. A patient with α-ketoadipic and α-aminoadipic aciduria , 1984, Journal of Inherited Metabolic Disease.
[32] H. Bremer,et al. Glutaric aciduria type II: report on a previously undescribed metabolic disorder. , 1976, Clinica chimica acta; international journal of clinical chemistry.
[33] C. Wilson,et al. α-Ketoadipic Aciduria: A Description of a New Metabolic Error in Lysine-Tryptophan Degradation , 1975, Pediatric Research.
[34] H. Höfler,et al. Isolation of the PAX9 cDNA from adult human esophagus , 2009, Mammalian Genome.
[35] L. Lettice,et al. Long-range gene control and genetic disease. , 2008, Advances in genetics.
[36] B. Ruggeri,et al. PAX genes: roles in development, pathophysiology, and cancer. , 2007, Biochemical pharmacology.
[37] K. Ohya,et al. Studies on the Transport Mechanism of Iron in Rat Incisor Enamel , 1991 .
[38] R. Brown,et al. Tryptophan and lysine metabolism in alpha-aminoadipic aciduria. , 1980, American journal of medical genetics.